Sichuan Hebang Biotechnology Co Ltd (603077) — Financial Flexibility Index
Sichuan Hebang Biotechnology Co Ltd (603077) has a Financial Flexibility Index of 0.03x as of September 2025. Free cash flow of CN¥366.16 Million (operating CF CN¥165.40 Million minus capex CN¥200.76 Million) represents 0% of total liabilities (CN¥10.53 Billion). Also explore Sichuan Hebang Biotechnology Co Ltd (603077) equity growth momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Sichuan Hebang Biotechnology Co Ltd Financial Flexibility Index (2009–2024)
Historical Financial Flexibility Index trend for Sichuan Hebang Biotechnology Co Ltd across 16 annual periods. Check Sichuan Hebang Biotechnology Co Ltd PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Sichuan Hebang Biotechnology Co Ltd (2009–2024)
Year-by-year free cash flow to debt coverage for Sichuan Hebang Biotechnology Co Ltd. For the full company profile including market capitalisation, see Sichuan Hebang Biotechnology Co Ltd market capitalisation.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.15x | CN¥1.58 Billion | CN¥467.93 Million | CN¥10.64 Billion | ▼ -37.5% |
| 2023 | 0.24x | CN¥1.03 Billion | CN¥200.76 Million | CN¥4.32 Billion | ▼ -71.1% |
| 2022 | 0.83x | CN¥3.58 Billion | CN¥2.64 Billion | CN¥4.34 Billion | ▼ -45.0% |
| 2021 | 1.50x | CN¥4.93 Billion | CN¥3.20 Billion | CN¥3.29 Billion | ▲ +810.5% |
| 2020 | 0.16x | CN¥565.95 Million | CN¥368.85 Million | CN¥3.43 Billion | ▼ -39.5% |
| 2019 | 0.27x | CN¥825.46 Million | CN¥162.92 Million | CN¥3.03 Billion | ▼ -56.5% |
| 2018 | 0.63x | CN¥1.31 Billion | CN¥944.39 Million | CN¥2.09 Billion | ▲ +67.6% |
| 2017 | 0.37x | CN¥685.48 Million | CN¥176.94 Million | CN¥1.83 Billion | ▼ -35.8% |
| 2016 | 0.58x | CN¥1.25 Billion | CN¥575.26 Million | CN¥2.15 Billion | ▲ +70.1% |
| 2015 | 0.34x | CN¥1.58 Billion | CN¥449.20 Million | CN¥4.62 Billion | ▲ +62.7% |
| 2014 | 0.21x | CN¥921.44 Million | CN¥204.67 Million | CN¥4.38 Billion | ▲ +152.4% |
| 2013 | 0.08x | CN¥191.06 Million | CN¥-407.48 Million | CN¥2.29 Billion | ▼ -66.5% |
| 2012 | 0.25x | CN¥408.79 Million | CN¥134.96 Million | CN¥1.64 Billion | ▼ -35.1% |
| 2011 | 0.38x | CN¥897.73 Million | CN¥552.56 Million | CN¥2.34 Billion | ▼ -8.8% |
| 2010 | 0.42x | CN¥901.77 Million | CN¥330.77 Million | CN¥2.14 Billion | ▲ +11.4% |
| 2009 | 0.38x | CN¥917.49 Million | CN¥68.97 Million | CN¥2.43 Billion | — |